Sign In
Buy NVO
$47.41
-0.0100 (-0.0211%)
At Close: Jun 24, 2026
Breakfast News: Futures Slide on Trump's EU Threat
07:30am, Tuesday, 20'th Jan 2026
Geopolitics sends the S&P 500 lower, Netflix leads busy earnings week, and more
Europe's Growth At Risk If Trump Acts On Greenland, Goldman Sachs Warns
01:05pm, Monday, 19'th Jan 2026
Goldman Sachs warns Europe's growth could face pressure if Trump follows through on Greenland-linked tariffs, though inflation effects would likely remain limited.
Is Novo Nordisk's Oral Wegovy Driving Strong Early US Demand Already?
11:01am, Monday, 19'th Jan 2026
NVO shares jump 9.1% as early U.S. prescriptions for oral Wegovy show strong first-week demand after its early January launch.
JCIC Asset Management Inc. Invests $2 Million in Novo Nordisk A/S $NVO
05:24am, Monday, 19'th Jan 2026
JCIC Asset Management Inc. acquired a new stake in Novo Nordisk A/S (NYSE: NVO) in the undefined quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional in
57,406 Shares in Novo Nordisk A/S $NVO Purchased by Capital Advisory Group Advisory Services LLC
04:48am, Monday, 19'th Jan 2026
Capital Advisory Group Advisory Services LLC bought a new stake in Novo Nordisk A/S (NYSE: NVO) during the undefined quarter, according to the company in its most recent 13F filing with the Securities
Market Today: Chips, energy and housing lead -- TSM, MU, NVO in focus
05:35pm, Friday, 16'th Jan 2026
Guru Stock PicksRichard Pzena has made the following transactions:Add in MBUU by 2.48%Stock News Stocks end flat as chips rally: Taiwan Semiconductor (TSM) and
Novo Nordisk Jumps on Higher Wegovy Dose
01:21pm, Friday, 16'th Jan 2026
Novo Nordisk (NVO) shares jumped early Friday after UK regulators cleared a higher weekly dose of the company's Wegovy weight loss injection, opening the door t
Novo Nordisk Stock Jumps. The Wegovy Pill Is Back in Focus
12:59pm, Friday, 16'th Jan 2026
Novo Nordisk (NVO) shares climbed about 4% on Friday, touching levels last seen in October, after early U.S. prescription data for its Wegovy weight-loss pill p
Eli Lilly vs. Novo Nordisk: Which Is the Better Stock Buy?
12:46pm, Friday, 16'th Jan 2026
Eli Lilly leads the weight loss market ahead of Novo Nordisk. Eli Lilly also has a more diversified lineup of products than its peer.
Trump's Greenland ambition: stocks that may face tariff shock in 2026
12:15pm, Friday, 16'th Jan 2026
EU stocks are in focus on Jan. 16 after President Donald Trump signalled plans of slapping tariffs on nations resisting Washington's push to acquire Greenland. “We need Greenland for national securi
Novo Nordisk's Newly Approved Weight Loss Pill Shows Record Prescription Data
12:07pm, Friday, 16'th Jan 2026
Novo Nordisk A/S' (NYSE: NVO) stock is trading higher on Friday as the Wegovy (semaglutide) pill hit 3,071 U.S. prescriptions in the first four days after its launch, Reuters noted, citing IQVIA data.
Novo Nordisk shares rise 5% after Wegovy obesity pill has ‘solid' launch
11:30am, Friday, 16'th Jan 2026
Shares of Novo Nordisk rose more than 5% on Friday after early prescription data showed an encouraging start to the launch of the company's new GLP-1 pill for obesity in the U.S. In a Friday note, TD
Why A 'Solid' First Week For Oral Wegovy Bodes Well For Novo And Lilly
09:33am, Friday, 16'th Jan 2026
Novo Nordisk's oral Wegovy snagged 3,071 prescriptions in its first week on the market, an analyst said Friday as Novo Nordisk stock jumped.
Novo Nordisk's Wegovy Weight Loss Shot Approved At Higher Dose in U.K.
09:26am, Friday, 16'th Jan 2026
The U.K.'s health regulator approved a higher dose of Novo Nordisk's Wegovy weight-loss drug applicable to patients with a body mass index of at least 30.
Novo's Wegovy pill tracks 3,071 prescriptions in first days of launch
07:43am, Friday, 16'th Jan 2026
Novo Nordisk's Wegovy pill hit 3,071 U.S. prescriptions in the first four days after its launch, IQVIA data shared by analysts on Friday showed, as investors closely watch to see if the firm can ram h
